SlideShare a Scribd company logo
1 of 52
1
Clinical pharmacokinetic
equations and calculations
Mohammad Issa Saleh
2
One vs. two compartments
3
One vs. two compartments
Two compartments
IV bolus
One compartment
IV bolus
4
One vs. two compartments
 In many cases, the drug distributes
from the blood into the tissues
quickly, and a pseudoequilibrium of
drug movement between blood and
tissues is established rapidly. When
this occurs, a one-compartment
model can be used to describe the
serum concentrations of a drug.
5
One vs. two compartments
 In some clinical situations, it is
possible to use a one-compartment
model to compute doses for a drug
even if drug distribution takes time
to complete. In this case, drug
serum concentrations are not
obtained in a patient until after the
distribution phase is over.
6
One-compartment model equations
 IV bolus
 IV infusion
 Extravascular
7
Intravenous Bolus Equation
 When a drug is given as an
intravenous bolus and the drug
distributes from the blood into the
tissues quickly, the serum
concentrations often decline in a
straight line when plotted on
semilogarithmic axes (Figure next
slide).
8
Intravenous Bolus Equation
 In this case, a one-compartment
model intravenous bolus equation
can be used:
t
K
e
Vd
D
C 


9
Intravenous Bolus Equation
t
K
e
Vd
D
C 


10
Intravenous Bolus
 Most drugs given intravenously cannot be
given as an actual intravenous bolus
because of side effects related to rapid
injection.
 A short infusion of 5–30 minutes can
avoid these types of adverse effects
 If the intravenous infusion time is very
short compared to the half-life of the drug
so that a large amount of drug is not
eliminated during the infusion time,
intravenous bolus equations can still be
used.
11
Very short infusion time compared to
the half-life
 For example, a patient is given a
theophylline loading dose of 400 mg
intravenously over 20 minutes.
Because the patient received
theophylline during previous
hospitalizations, it is known that the
volume of distribution is 30 L, the
elimination rate constant equals
0.116 h−1, and the half-life (t1/2) is
6 hours (t1/2 = 0.693/ke =
0.693/0.115 h−1 = 6 h).
12
Very short infusion time compared to
the half-life
 To compute the expected
theophylline concentration 4 hours
after the dose was given, a one-
compartment model intravenous
bolus equation can be used:
mg/L
8.4
e
L
30
mg
400
e
Vd
D
C 4
0.115
t
K


 



13
Slow infusion and/or distribution
 If drug distribution is not rapid, it is
still possible to use a one
compartment model intravenous
bolus equation if the duration of the
distribution phase and infusion time
is small compared to the half-life of
the drug and only a small amount of
drug is eliminated during the
infusion and distribution phases
14
Slow infusion and/or distribution
 For instance, vancomycin must be infused
slowly over 1 hour in order to avoid
hypotension and red flushing around the
head and neck areas. Additionally,
vancomycin distributes slowly to tissues
with a 1/2–1 hour distribution phase.
Because the half-life of vancomycin in
patients with normal renal function is
approximately 8 hours, a one
compartment model intravenous bolus
equation can be used to compute
concentrations in the postinfusion,
postdistribution phase without a large
amount of error.
15
Slow infusion and/or distribution
 As an example of this approach (previous slide), a
patient is given an intravenous dose of
vancomycin 1000 mg. Since the patient has
received this drug before, it is known that the
volume of distribution equals 50 L, the elimination
rate constant is 0.077 h−1, and the half-life
equals 9 h (t1/2 = 0.693/ke = 0.693/0.077 h−1
= 9 h).
 To calculate the expected vancomycin
concentration 12 hours after the dose was given,
a one compartment model intravenous bolus
equation can be used:
mg/L
7.9
e
L
50
mg
1000
e
Vd
D
C 12
0.077
t
K


 



16
Estimating individual Pharmacokinetic
parameters: IV bolus
1. Plotting
2. Simple fitting (will not be
discussed)
3. Calculation
17
Estimating individual PK parameters:
plotting
 For example, a patient was given an
intravenous loading dose of phenobarbital
600 mg over a period of about an hour.
One day and four days after the dose was
administered phenobarbital serum
concentrations were 12.6 mg/L and 7.5
mg/L, respectively.
 By plotting the serum concentration/time
data on semilogarithmic axes, the time it
takes for serum concentrations to
decrease by one-half can be determined
and is equal to 4 days.
18
Estimating individual PK parameters:
plotting
19
Estimating individual PK parameters:
plotting
 The elimination rate constant can be
computed using the following
relationship:
 The extrapolated concentration at
time = 0 (C0 = 15 mg/L in this
case) can be used to calculate the
volume of distribution:
1
-
2
/
1
day
173
.
0
4
0.693
t
0.693



Ke
L
40
15
600
D
V
0



C
20
Estimating individual PK parameters:
Calculation
 Alternatively, these parameters could be
obtained by calculation without plotting
the concentrations.
 The elimination rate constant can be
computed using the following equation:
where t1 and C1 are the first
time/concentration pair and t2 and C2 are
the second time/concentration pair
day
0.173
4
-
1
ln(7.5)
-
ln(12.6)
-
t
-
t
)
ln(C
-
)
ln(C
-
Ke 1
-
2
1
2
1

















21
Estimating individual PK parameters:
Calculation
 The elimination rate constant can be
converted into the half-life using the
following equation:
days
4
173
.
0
0.693
0.693
t 2
/
1 


Ke
22
Estimating individual PK parameters:
Calculation
 The serum concentration at time = zero
(C0) can be computed using a variation of
the intravenous bolus equation:
where t and C are a time/concentration pair
The volume of distribution (V) :
t
Ke
e
C
C .
0 

mg/L
15.0
e
12.6
C 0.173.1
0 
 
L
40
15
600
D
V
0



C
23
Continuous intravenous infusion
(one-compartment model)
Dr Mohammad Issa
24
IV infusion
0
5
10
15
20
25
30
35
0 5 10 15 20 25 30 35 40
Time
Concentration
During infusion Post infusion
25
IV infusion: during infusion
0
5
10
15
20
25
30
35
0 5 10 15 20 25 30 35 40
Time
Concentration
where K0 is the infusion
rate, K is the elimination
rate constant, and Vd is
the volume of distribution
)
1
( e
Kt
o
K
K
X



)
1
( e
Kt
o
p
KVd
K
C



26
Steady state
0
5
10
15
20
25
30
35
0 5 10 15 20 25 30 35 40
Time
Concentration
≈ steady state
concentration (Css)
KVd
K
C
o
ss 
27
Steady state
 At steady state the input rate (infusion
rate) is equal to the elimination rate.
 This characteristic of steady state is valid
for all drugs regardless to the
pharmacokinetic behavior or the route of
administration.
 At least 5 t1/2 are needed to get to 95% of
Css
 At least 7 t1/2 are needed to get to 99% of
Css
 5-7 t1/2 are needed to get to Css
28
IV infusion + Loading IV bolus
 To achieve a target steady state
conc (Css) the following equations
can be used:
 For the infusion rate:
 For the loading dose:
ss
C
Cl
K 

0
ss
C
Vd
LD 

29
Concentration
Concentration
Concentration
Concentration
Half-lives
Half-lives
Half-lives
Half-lives
Case A
Infusion alone
(K0= Css∙Cl)
Case B
Infusion (K0= Css∙Cl)
loading bolus (LD= Css∙Vd)
Case D
Infusion (K0= Css∙Cl)
loading bolus (LD< Css∙Vd)
Case C
Infusion (K0= Css∙Cl)
loading bolus (LD > Css∙Vd)
Scenarios with different LD
30
Post infusion phase
0
5
10
15
20
25
30
35
0 5 10 15 20 25 30 35 40
Time
Concentration
During infusion Post infusion
Cend
(Concentration
at the end of
the infusion)
e
Kt
end
postinf C
C



)
1
( e
KT
o
end
KVd
K
C



t is the post infusion time
T is the infusion duration
31
Post infusion phase data
 Half-life and elimination rate
constant calculation
 Volume of distribution estimation
32
Elimination rate constant calculation
using post infusion data
 K can be estimated using post
infusion data by:
 Plotting log(Conc) vs. time
 From the slope estimate K:
303
.
2
k
Slope 

33
Volume of distribution calculation using
post infusion data
 If you reached steady state conc
(C* = CSS):
 where k is estimated as described in
the previous slide
ss
ss
C
K
K
Vd
Vd
K
K
C




 0
0
34
Volume of distribution calculation using
post infusion data
 If you did not reached steady state
(C* = CSS(1-e-kT)):
)
1
(
*
)
1
(
* 0
0 kT
kT
e
C
k
k
Vd
e
Vd
k
k
C 








35
Example 1
Following a two-hour infusion of 100
mg/hr plasma was collected and
analysed for drug concentration.
Calculate kel and V.
Time relative
to infusion
cessation
(hr)
1 3 7 10 16 22
Cp (mg/L) 12 9 8 5 3.9 1.7
36
Post infusion data
y = -0.0378x + 1.1144
R2
= 0.9664
0
0.2
0.4
0.6
0.8
1
1.2
0 5 10 15 20 25
Time (hr)
Log(Conc)
mg/L
Time is the time after stopping the infusion
37
Example 1
 From the slope, K is estimated to
be:
 From the intercept, C* is estimated
to be:
1/hr
0.087
0.0378
2.303
Slope
2.303
k 







mg/L
13
10
C*
1.1144
intercept
log(C*)
1.1144




38
Example 1
 Since we did not get to steady
state:
L
14.1
)
e
(1
(13)
(0.087)
100
Vd
)
e
(1
*
C
k
k
Vd
2
0.087*
kT
0









39
Example 2
 Estimate the volume of distribution
(22 L), elimination rate constant
(0.28 hr-1), half-life (2.5 hr), and
clearance (6.2 L/hr) from the data in
the following table obtained on
infusing a drug at the rate of 50
mg/hr for 16 hours.
Time
(hr)
0 2 4 6 10 12 15 16 18 20 24
Conc
(mg/L)
0 3.48 5.47 6.6 7.6 7.8 8 8 4.6 2.62 0.85
40
Example 2
41
Example 2
1. Calculating clearance:
It appears from the data that the
infusion has reached steady state:
(CP(t=15) = CP(t=16) = CSS)
L/hr
25
.
6
mg/L
8
mg/hr
50
0
0





SS
SS
C
K
Cl
Cl
K
C
42
Example 2
2. Calculating elimination rate constant
and half life:
From the post infusion data, K and t1/2 can
be estimated. The concentration in the
post infusion phase is described
according to:
where t1 is the time after stopping the
infusion. Plotting log(Cp) vs. t1 results
in the following:
1
303
.
2
)
log(
)
log(
1
t
K
C
C
e
C
C SS
P
t
K
SS
P 



 

43
Example 2
y = -0.1218x + 0.9047
R2
= 1
-0.2
0
0.2
0.4
0.6
0.8
1
0 1 2 3 4 5 6 7 8 9
Post infusion time (hr)
log(Conc)
(mg/L)
44
Example 2
K=-slope*2.303=0.28 hr-1
Half life = 0.693/K=0.693/0.28=
2.475 hr
3. Calculating volume of distribution:
L
3
.
22
hr
28
.
0
L/hr
25
.
6
1
-



K
Cl
VD
45
Example 3
 For prolonged surgical procedures,
succinylcholine is given by IV
infusion for sustained muscle
relaxation. A typical initial dose is 20
mg followed by continuous infusion
of 4 mg/min. the infusion must be
individualized because of variation in
the kinetics of metabolism of
suucinylcholine. Estimate the
elimination half-lives of
succinylcholine in patients requiring
0.4 mg/min and 4 mg/min,
respectively, to maintain 20 mg in the
body. (35 and 3.5 min)
46
Example 3
For the patient requiring 0.4 mg/min:
For the patient requiring 4 mg/min:
0
2
/
1
2
/
1
0
693
.
0
693
.
0 K
A
t
t
K
K
K
A SS
o
ss






min
65
.
34
4
.
0
)
693
.
0
)(
20
(
693
.
0
0
2
/
1 



K
A
t SS
min
465
.
3
4
)
693
.
0
)(
20
(
693
.
0
0
2
/
1 



K
A
t SS
47
Example 4
A drug is administered as a short
term infusion. The average
pharmacokinetic parameters for
this
drug are:
K = 0.40 hr-1
Vd = 28 L
This drug follows a one-
compartment body model.
48
Example 4
1) A 300 mg dose of this drug is given
as a short-term infusion over 30
minutes. What is the infusion rate?
What will be the plasma
concentration at the end of the
infusion?
2) How long will it take for the plasma
concentration to fall to 5.0 mg/L?
3) If another infusion is started 5.5
hours after the first infusion was
stopped, what will the plasma
concentration be just before the
second infusion?
49
Example 4
1) The infusion rate (K0) =
Dose/duration = 300 mg/0.5 hr =
600 mg/hr.
Plasma concentration at the end of
the infusion:
Infusion phase:
 
mg/L
71
.
9
)
1
(
L)
28
)(
hr
4
.
0
(
mg/hr
600
hr)
5
.
0
(
1
C
)
5
.
0
)(
4
.
0
(
1
-
0
P










e
t
C
e
V
K
K
P
t
K
D
50
Example 4
2) Post infusion phase:
The concentration will fall to 5.0 mg/L
1.66 hr after the infusion was
stopped.
hr
1.66
0.4
ln(5)
ln(9.71)
K
)
ln(C
-
infusion))
of
end
(at the
ln(C
t
t
K
-
infusion))
of
end
(at the
ln(C
)
ln(C
e
infusion)
of
end
(at the
C
C
P
P
2
2
P
P
t
k
P
P
2









 

51
Example 4
3) Post infusion phase (conc 5.5 hrs
after stopping the infusion):
mg/L
08
.
1
9.71)e
(
hr)
5.5
(t
C
e
infusion)
of
end
(at the
C
C
-.4)(5.5)
(-0
p
t
k
P
P
2




 

52

More Related Content

What's hot

Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensAreej Abu Hanieh
 
Clinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghelaClinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghelajpv2212
 
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactions
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactionsIntroduction to pharmacokinetics &amp; pharmacodynamics, drug interactions
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactionsSimmuaditya1996
 
Bp 604 t unit 1 lecture 1
Bp 604 t unit 1 lecture 1Bp 604 t unit 1 lecture 1
Bp 604 t unit 1 lecture 1D2 SIR
 
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)Muavia Sarwar
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorptionAravinda Palyam
 
Drug distribution
Drug distributionDrug distribution
Drug distributionNaser Tadvi
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusAreej Abu Hanieh
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
Multicompartment model IV Bolus
Multicompartment model IV BolusMulticompartment model IV Bolus
Multicompartment model IV BolusHopeMasalu
 
Non compartmental analysis
Non compartmental analysisNon compartmental analysis
Non compartmental analysisFarjanaYeasmin7
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug bindingSnehal Patel
 

What's hot (20)

Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimensPharmacokinetics / Biopharmaceutics - Multi dosage regimens
Pharmacokinetics / Biopharmaceutics - Multi dosage regimens
 
Clinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghelaClinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghela
 
drug absorption lecture
drug absorption lecturedrug absorption lecture
drug absorption lecture
 
Pharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosingPharmacokinetics of multiple dosing
Pharmacokinetics of multiple dosing
 
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactions
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactionsIntroduction to pharmacokinetics &amp; pharmacodynamics, drug interactions
Introduction to pharmacokinetics &amp; pharmacodynamics, drug interactions
 
Bp 604 t unit 1 lecture 1
Bp 604 t unit 1 lecture 1Bp 604 t unit 1 lecture 1
Bp 604 t unit 1 lecture 1
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)
Pharmacy Internship Report (Apprentice, Community Pharmacist, Retail Pharmacist)
 
Pharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug AbsorptionPharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug Absorption
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Role of cytochrome p450 in drug
Role of cytochrome p450 in drugRole of cytochrome p450 in drug
Role of cytochrome p450 in drug
 
Protein binding
Protein bindingProtein binding
Protein binding
 
Bioequivalence protocol
Bioequivalence  protocolBioequivalence  protocol
Bioequivalence protocol
 
Multicompartment model IV Bolus
Multicompartment model IV BolusMulticompartment model IV Bolus
Multicompartment model IV Bolus
 
Non compartmental analysis
Non compartmental analysisNon compartmental analysis
Non compartmental analysis
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 

Similar to Clinical pharmacokinetic equations and calculations explained

One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV InfusionLakshmiChandran20
 
05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.pptNoorelhuda2
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugShivankan Kakkar
 
one compartment open model
one compartment open model one compartment open model
one compartment open model NadiaSraboni
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxSARADPAWAR1
 
2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptxjiregna5
 
Compartment modeling
Compartment modelingCompartment modeling
Compartment modelingSHILPI BISWAS
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya Udupa
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)MdNazmulIslamTanmoy
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical scienceskhalafpharm
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxrameshjanga11
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationMalla Reddy College of Pharmacy
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics Umesh Yadav
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 

Similar to Clinical pharmacokinetic equations and calculations explained (20)

One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt05_Multiple dosing IV bolus.ppt
05_Multiple dosing IV bolus.ppt
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given DrugCalculate and Interpret Pharmacokinetic Parameters of a Given Drug
Calculate and Interpret Pharmacokinetic Parameters of a Given Drug
 
one compartment open model
one compartment open model one compartment open model
one compartment open model
 
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptxCalculation of the plasma drug levels after a single dose IVinfusion..pptx
Calculation of the plasma drug levels after a single dose IVinfusion..pptx
 
2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx2. Basic Phk-IV and EV.pptx
2. Basic Phk-IV and EV.pptx
 
Compartment modeling
Compartment modelingCompartment modeling
Compartment modeling
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parameters
 
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)Biopharmaceutics & Pharmacokinetics (Ultimate final note)
Biopharmaceutics & Pharmacokinetics (Ultimate final note)
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
iv infusions.pptx
iv infusions.pptxiv infusions.pptx
iv infusions.pptx
 
Pharmacokinetic Models
Pharmacokinetic ModelsPharmacokinetic Models
Pharmacokinetic Models
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
A seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administrationA seminar on one & two compartment open model extra vascular administration
A seminar on one & two compartment open model extra vascular administration
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 

More from Noorelhuda2

Research methodology and rules for puplication
Research methodology and rules for puplicationResearch methodology and rules for puplication
Research methodology and rules for puplicationNoorelhuda2
 
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxNoorelhuda2
 
chapter17 (1).ppt
chapter17 (1).pptchapter17 (1).ppt
chapter17 (1).pptNoorelhuda2
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNoorelhuda2
 
محاضرة النقابة.pptx
محاضرة النقابة.pptxمحاضرة النقابة.pptx
محاضرة النقابة.pptxNoorelhuda2
 
chapter-alkene.ppt
chapter-alkene.pptchapter-alkene.ppt
chapter-alkene.pptNoorelhuda2
 
Lec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxLec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxNoorelhuda2
 
first lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptfirst lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptNoorelhuda2
 
analytical-referance calibration.ppt
analytical-referance calibration.pptanalytical-referance calibration.ppt
analytical-referance calibration.pptNoorelhuda2
 
acid-base-equilebria.ppt
acid-base-equilebria.pptacid-base-equilebria.ppt
acid-base-equilebria.pptNoorelhuda2
 
insilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxinsilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxNoorelhuda2
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxNoorelhuda2
 
stereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxstereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxNoorelhuda2
 
ppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxNoorelhuda2
 
group-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxgroup-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxNoorelhuda2
 

More from Noorelhuda2 (20)

Research methodology and rules for puplication
Research methodology and rules for puplicationResearch methodology and rules for puplication
Research methodology and rules for puplication
 
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptxödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
ödev Peptit Sentezleri- FKM620- Leyla hoca.pptx
 
chapter17 (1).ppt
chapter17 (1).pptchapter17 (1).ppt
chapter17 (1).ppt
 
chapter11.ppt
chapter11.pptchapter11.ppt
chapter11.ppt
 
7319186.ppt
7319186.ppt7319186.ppt
7319186.ppt
 
New Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptxNew Microsoft PowerPoint Presentation.pptx
New Microsoft PowerPoint Presentation.pptx
 
محاضرة النقابة.pptx
محاضرة النقابة.pptxمحاضرة النقابة.pptx
محاضرة النقابة.pptx
 
chapter-alkene.ppt
chapter-alkene.pptchapter-alkene.ppt
chapter-alkene.ppt
 
Lec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptxLec-2-Pharmacognosy.pptx
Lec-2-Pharmacognosy.pptx
 
lecture-2.ppt
lecture-2.pptlecture-2.ppt
lecture-2.ppt
 
first lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.pptfirst lecture-Pharmaceutical Analytical chemistry.ppt
first lecture-Pharmaceutical Analytical chemistry.ppt
 
analytical-referance calibration.ppt
analytical-referance calibration.pptanalytical-referance calibration.ppt
analytical-referance calibration.ppt
 
acid-base-equilebria.ppt
acid-base-equilebria.pptacid-base-equilebria.ppt
acid-base-equilebria.ppt
 
10206462.ppt
10206462.ppt10206462.ppt
10206462.ppt
 
insilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptxinsilicodrugdesigining-170222171857 (1).pptx
insilicodrugdesigining-170222171857 (1).pptx
 
cadd-191129134050 (1).pptx
cadd-191129134050 (1).pptxcadd-191129134050 (1).pptx
cadd-191129134050 (1).pptx
 
stereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptxstereoisomersautosaved-190208040126.pptx
stereoisomersautosaved-190208040126.pptx
 
DD.pptx
DD.pptxDD.pptx
DD.pptx
 
ppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptxppt-lec-13-chem-260-fall-2013.pptx
ppt-lec-13-chem-260-fall-2013.pptx
 
group-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptxgroup-01-stereochemistry-210827075815 (1).pptx
group-01-stereochemistry-210827075815 (1).pptx
 

Recently uploaded

IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 

Recently uploaded (20)

IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 

Clinical pharmacokinetic equations and calculations explained

  • 1. 1 Clinical pharmacokinetic equations and calculations Mohammad Issa Saleh
  • 2. 2 One vs. two compartments
  • 3. 3 One vs. two compartments Two compartments IV bolus One compartment IV bolus
  • 4. 4 One vs. two compartments  In many cases, the drug distributes from the blood into the tissues quickly, and a pseudoequilibrium of drug movement between blood and tissues is established rapidly. When this occurs, a one-compartment model can be used to describe the serum concentrations of a drug.
  • 5. 5 One vs. two compartments  In some clinical situations, it is possible to use a one-compartment model to compute doses for a drug even if drug distribution takes time to complete. In this case, drug serum concentrations are not obtained in a patient until after the distribution phase is over.
  • 6. 6 One-compartment model equations  IV bolus  IV infusion  Extravascular
  • 7. 7 Intravenous Bolus Equation  When a drug is given as an intravenous bolus and the drug distributes from the blood into the tissues quickly, the serum concentrations often decline in a straight line when plotted on semilogarithmic axes (Figure next slide).
  • 8. 8 Intravenous Bolus Equation  In this case, a one-compartment model intravenous bolus equation can be used: t K e Vd D C   
  • 10. 10 Intravenous Bolus  Most drugs given intravenously cannot be given as an actual intravenous bolus because of side effects related to rapid injection.  A short infusion of 5–30 minutes can avoid these types of adverse effects  If the intravenous infusion time is very short compared to the half-life of the drug so that a large amount of drug is not eliminated during the infusion time, intravenous bolus equations can still be used.
  • 11. 11 Very short infusion time compared to the half-life  For example, a patient is given a theophylline loading dose of 400 mg intravenously over 20 minutes. Because the patient received theophylline during previous hospitalizations, it is known that the volume of distribution is 30 L, the elimination rate constant equals 0.116 h−1, and the half-life (t1/2) is 6 hours (t1/2 = 0.693/ke = 0.693/0.115 h−1 = 6 h).
  • 12. 12 Very short infusion time compared to the half-life  To compute the expected theophylline concentration 4 hours after the dose was given, a one- compartment model intravenous bolus equation can be used: mg/L 8.4 e L 30 mg 400 e Vd D C 4 0.115 t K       
  • 13. 13 Slow infusion and/or distribution  If drug distribution is not rapid, it is still possible to use a one compartment model intravenous bolus equation if the duration of the distribution phase and infusion time is small compared to the half-life of the drug and only a small amount of drug is eliminated during the infusion and distribution phases
  • 14. 14 Slow infusion and/or distribution  For instance, vancomycin must be infused slowly over 1 hour in order to avoid hypotension and red flushing around the head and neck areas. Additionally, vancomycin distributes slowly to tissues with a 1/2–1 hour distribution phase. Because the half-life of vancomycin in patients with normal renal function is approximately 8 hours, a one compartment model intravenous bolus equation can be used to compute concentrations in the postinfusion, postdistribution phase without a large amount of error.
  • 15. 15 Slow infusion and/or distribution  As an example of this approach (previous slide), a patient is given an intravenous dose of vancomycin 1000 mg. Since the patient has received this drug before, it is known that the volume of distribution equals 50 L, the elimination rate constant is 0.077 h−1, and the half-life equals 9 h (t1/2 = 0.693/ke = 0.693/0.077 h−1 = 9 h).  To calculate the expected vancomycin concentration 12 hours after the dose was given, a one compartment model intravenous bolus equation can be used: mg/L 7.9 e L 50 mg 1000 e Vd D C 12 0.077 t K       
  • 16. 16 Estimating individual Pharmacokinetic parameters: IV bolus 1. Plotting 2. Simple fitting (will not be discussed) 3. Calculation
  • 17. 17 Estimating individual PK parameters: plotting  For example, a patient was given an intravenous loading dose of phenobarbital 600 mg over a period of about an hour. One day and four days after the dose was administered phenobarbital serum concentrations were 12.6 mg/L and 7.5 mg/L, respectively.  By plotting the serum concentration/time data on semilogarithmic axes, the time it takes for serum concentrations to decrease by one-half can be determined and is equal to 4 days.
  • 18. 18 Estimating individual PK parameters: plotting
  • 19. 19 Estimating individual PK parameters: plotting  The elimination rate constant can be computed using the following relationship:  The extrapolated concentration at time = 0 (C0 = 15 mg/L in this case) can be used to calculate the volume of distribution: 1 - 2 / 1 day 173 . 0 4 0.693 t 0.693    Ke L 40 15 600 D V 0    C
  • 20. 20 Estimating individual PK parameters: Calculation  Alternatively, these parameters could be obtained by calculation without plotting the concentrations.  The elimination rate constant can be computed using the following equation: where t1 and C1 are the first time/concentration pair and t2 and C2 are the second time/concentration pair day 0.173 4 - 1 ln(7.5) - ln(12.6) - t - t ) ln(C - ) ln(C - Ke 1 - 2 1 2 1                 
  • 21. 21 Estimating individual PK parameters: Calculation  The elimination rate constant can be converted into the half-life using the following equation: days 4 173 . 0 0.693 0.693 t 2 / 1    Ke
  • 22. 22 Estimating individual PK parameters: Calculation  The serum concentration at time = zero (C0) can be computed using a variation of the intravenous bolus equation: where t and C are a time/concentration pair The volume of distribution (V) : t Ke e C C . 0   mg/L 15.0 e 12.6 C 0.173.1 0    L 40 15 600 D V 0    C
  • 24. 24 IV infusion 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 40 Time Concentration During infusion Post infusion
  • 25. 25 IV infusion: during infusion 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 40 Time Concentration where K0 is the infusion rate, K is the elimination rate constant, and Vd is the volume of distribution ) 1 ( e Kt o K K X    ) 1 ( e Kt o p KVd K C   
  • 26. 26 Steady state 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 40 Time Concentration ≈ steady state concentration (Css) KVd K C o ss 
  • 27. 27 Steady state  At steady state the input rate (infusion rate) is equal to the elimination rate.  This characteristic of steady state is valid for all drugs regardless to the pharmacokinetic behavior or the route of administration.  At least 5 t1/2 are needed to get to 95% of Css  At least 7 t1/2 are needed to get to 99% of Css  5-7 t1/2 are needed to get to Css
  • 28. 28 IV infusion + Loading IV bolus  To achieve a target steady state conc (Css) the following equations can be used:  For the infusion rate:  For the loading dose: ss C Cl K   0 ss C Vd LD  
  • 29. 29 Concentration Concentration Concentration Concentration Half-lives Half-lives Half-lives Half-lives Case A Infusion alone (K0= Css∙Cl) Case B Infusion (K0= Css∙Cl) loading bolus (LD= Css∙Vd) Case D Infusion (K0= Css∙Cl) loading bolus (LD< Css∙Vd) Case C Infusion (K0= Css∙Cl) loading bolus (LD > Css∙Vd) Scenarios with different LD
  • 30. 30 Post infusion phase 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 40 Time Concentration During infusion Post infusion Cend (Concentration at the end of the infusion) e Kt end postinf C C    ) 1 ( e KT o end KVd K C    t is the post infusion time T is the infusion duration
  • 31. 31 Post infusion phase data  Half-life and elimination rate constant calculation  Volume of distribution estimation
  • 32. 32 Elimination rate constant calculation using post infusion data  K can be estimated using post infusion data by:  Plotting log(Conc) vs. time  From the slope estimate K: 303 . 2 k Slope  
  • 33. 33 Volume of distribution calculation using post infusion data  If you reached steady state conc (C* = CSS):  where k is estimated as described in the previous slide ss ss C K K Vd Vd K K C      0 0
  • 34. 34 Volume of distribution calculation using post infusion data  If you did not reached steady state (C* = CSS(1-e-kT)): ) 1 ( * ) 1 ( * 0 0 kT kT e C k k Vd e Vd k k C         
  • 35. 35 Example 1 Following a two-hour infusion of 100 mg/hr plasma was collected and analysed for drug concentration. Calculate kel and V. Time relative to infusion cessation (hr) 1 3 7 10 16 22 Cp (mg/L) 12 9 8 5 3.9 1.7
  • 36. 36 Post infusion data y = -0.0378x + 1.1144 R2 = 0.9664 0 0.2 0.4 0.6 0.8 1 1.2 0 5 10 15 20 25 Time (hr) Log(Conc) mg/L Time is the time after stopping the infusion
  • 37. 37 Example 1  From the slope, K is estimated to be:  From the intercept, C* is estimated to be: 1/hr 0.087 0.0378 2.303 Slope 2.303 k         mg/L 13 10 C* 1.1144 intercept log(C*) 1.1144    
  • 38. 38 Example 1  Since we did not get to steady state: L 14.1 ) e (1 (13) (0.087) 100 Vd ) e (1 * C k k Vd 2 0.087* kT 0         
  • 39. 39 Example 2  Estimate the volume of distribution (22 L), elimination rate constant (0.28 hr-1), half-life (2.5 hr), and clearance (6.2 L/hr) from the data in the following table obtained on infusing a drug at the rate of 50 mg/hr for 16 hours. Time (hr) 0 2 4 6 10 12 15 16 18 20 24 Conc (mg/L) 0 3.48 5.47 6.6 7.6 7.8 8 8 4.6 2.62 0.85
  • 41. 41 Example 2 1. Calculating clearance: It appears from the data that the infusion has reached steady state: (CP(t=15) = CP(t=16) = CSS) L/hr 25 . 6 mg/L 8 mg/hr 50 0 0      SS SS C K Cl Cl K C
  • 42. 42 Example 2 2. Calculating elimination rate constant and half life: From the post infusion data, K and t1/2 can be estimated. The concentration in the post infusion phase is described according to: where t1 is the time after stopping the infusion. Plotting log(Cp) vs. t1 results in the following: 1 303 . 2 ) log( ) log( 1 t K C C e C C SS P t K SS P       
  • 43. 43 Example 2 y = -0.1218x + 0.9047 R2 = 1 -0.2 0 0.2 0.4 0.6 0.8 1 0 1 2 3 4 5 6 7 8 9 Post infusion time (hr) log(Conc) (mg/L)
  • 44. 44 Example 2 K=-slope*2.303=0.28 hr-1 Half life = 0.693/K=0.693/0.28= 2.475 hr 3. Calculating volume of distribution: L 3 . 22 hr 28 . 0 L/hr 25 . 6 1 -    K Cl VD
  • 45. 45 Example 3  For prolonged surgical procedures, succinylcholine is given by IV infusion for sustained muscle relaxation. A typical initial dose is 20 mg followed by continuous infusion of 4 mg/min. the infusion must be individualized because of variation in the kinetics of metabolism of suucinylcholine. Estimate the elimination half-lives of succinylcholine in patients requiring 0.4 mg/min and 4 mg/min, respectively, to maintain 20 mg in the body. (35 and 3.5 min)
  • 46. 46 Example 3 For the patient requiring 0.4 mg/min: For the patient requiring 4 mg/min: 0 2 / 1 2 / 1 0 693 . 0 693 . 0 K A t t K K K A SS o ss       min 65 . 34 4 . 0 ) 693 . 0 )( 20 ( 693 . 0 0 2 / 1     K A t SS min 465 . 3 4 ) 693 . 0 )( 20 ( 693 . 0 0 2 / 1     K A t SS
  • 47. 47 Example 4 A drug is administered as a short term infusion. The average pharmacokinetic parameters for this drug are: K = 0.40 hr-1 Vd = 28 L This drug follows a one- compartment body model.
  • 48. 48 Example 4 1) A 300 mg dose of this drug is given as a short-term infusion over 30 minutes. What is the infusion rate? What will be the plasma concentration at the end of the infusion? 2) How long will it take for the plasma concentration to fall to 5.0 mg/L? 3) If another infusion is started 5.5 hours after the first infusion was stopped, what will the plasma concentration be just before the second infusion?
  • 49. 49 Example 4 1) The infusion rate (K0) = Dose/duration = 300 mg/0.5 hr = 600 mg/hr. Plasma concentration at the end of the infusion: Infusion phase:   mg/L 71 . 9 ) 1 ( L) 28 )( hr 4 . 0 ( mg/hr 600 hr) 5 . 0 ( 1 C ) 5 . 0 )( 4 . 0 ( 1 - 0 P           e t C e V K K P t K D
  • 50. 50 Example 4 2) Post infusion phase: The concentration will fall to 5.0 mg/L 1.66 hr after the infusion was stopped. hr 1.66 0.4 ln(5) ln(9.71) K ) ln(C - infusion)) of end (at the ln(C t t K - infusion)) of end (at the ln(C ) ln(C e infusion) of end (at the C C P P 2 2 P P t k P P 2            
  • 51. 51 Example 4 3) Post infusion phase (conc 5.5 hrs after stopping the infusion): mg/L 08 . 1 9.71)e ( hr) 5.5 (t C e infusion) of end (at the C C -.4)(5.5) (-0 p t k P P 2       
  • 52. 52